© 2020 – 2024 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
Image default
Business

AstraZeneca’s vaccine is suffering from a PR problem. The economic costs could be considerable

Scientists and several regulatory agencies say its safe and the data that’s caused some to raise concerns about blood clots looks shaky, but some countries have suspended the treatment. There’s a whiff of the false MMR/autism scare in the air, writes James Moore

Related posts

The Post Office is appointing postmasters to its board. Such progressive thinking is terribly rare

AEA3

Think globally, act locally: creating a positive impact

AEA3

Mastercard set to face UK’s largest class action over fees

AEA3